Sebastien Gibot
Inventor
Stats
- 6 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 6 US Patents Issued
- 10 US Applications Filed
- 61 Total Citation Count
- Feb 18, 2020 Most Recent Filing
- Jan 27, 2005 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
BIOXELL S.P.A. | 2
2 | 2005
2009 |
INOTREM | 1
| 2014
|
Université Henri Poincaré-Nancy I | 1
| 2005
|
UNIVERSITE HENRI POINCARE - NANCY I | 3
| 2005
|
BIOXELL S P.A. | 2
| 2005
|
UNIVERSITE HENRI POINCARE NANCY 1 | 2
| 2005
|
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | 2
2 1 2 | 2011
2013 2014 2015 |
UNIVERSITE DE LORRAINE | 2
2 4 2 1 3 | 2005
2009 2011 2013 2014 2015 |
APHP (ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS) | 1
| 2014
|
BRISTOL-MYERS SQUIBB COMPANY | 2
2 1 | 2009
2011 2015 |
Inventor Addresses
Address | Duration |
---|---|
Nancy, FR | Nov 02, 06 - May 23, 17 |
Remereville, FR | Jun 30, 16 - Mar 16, 21 |
Vandoeuvre Les Nancy, FR | Oct 08, 09 - Aug 13, 20 |
Vandoeuvre les Nancy, FR | Dec 06, 07 - Mar 31, 20 |
Vandoeuvres-les-Nancy, FR | Jan 31, 13 - Nov 14, 17 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 8 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
C07K: | PEPTIDES | 8 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
10948498 | 2021 | Methods and kits for predicting the risk of having a cardiovascular disease or event | 0 |
2020/0254,058 | 2020 | THERAPEUTIC TREM-1 PEPTIDES | 0 |
10603357 | 2020 | Therapeutic TREM-1 peptides | 0 |
9815883 | 2017 | Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof | 0 |
9657081 | 2017 | Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases | 2 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.